0001209191-23-014626.txt : 20230302
0001209191-23-014626.hdr.sgml : 20230302
20230302161317
ACCESSION NUMBER: 0001209191-23-014626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230228
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oakes Gregory
CENTRAL INDEX KEY: 0001809796
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39971
FILM NUMBER: 23699073
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Landos Biopharma, Inc.
CENTRAL INDEX KEY: 0001785345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815085535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 540-818-2844
MAIL ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-28
0
0001785345
Landos Biopharma, Inc.
LABP
0001809796
Oakes Gregory
C/O LANDOS BIOPHARMA, INC.
PO BOX 11239
BLACKSBURG
VA
24062
1
1
0
0
Chief Executive Officer
Employee Stock Option (right to buy)
0.37
2023-02-28
4
A
0
475300
0.00
A
2033-02-27
Common Stock
475300
475300
D
1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
/s/ Gregory Oakes
2023-03-02